Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 1,375 shares at $36.72 ($50K) on 2021-07-13, disclosed to the SEC on 2021-07-14.
Open-market sale of $50k VIR by EVP, Research & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VIR | SELL | 2022-02-09 | $47K | — | Filing → |
| VIR | SELL | 2022-01-26 | $45K | — | Filing → |
| VIR | SELL | 2022-01-13 | $48K | — | Filing → |